Press Releases

Text/HTML

College Endorses New Canadian Guideline for Opioid Prescribing  

At its May 26 meeting, the Council of the College of Physicians and Surgeons of Nova Scotia endorsed the new 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain as best practices for physicians in Nova Scotia.


College Approves Mifegymiso Prescribing Standard  

Health Canada approved the drug Mifegymiso, a two-drug combination product that provides a non-surgical option for early abortion, in July 2015. Mifegyimso became available to the Canadian public in January 2017.


College Endorses the US Centres for Disease Control and Prevention's Guidelines for Prescribing Opioids for Chronic Pain  

At its May 27th meeting, the College Council endorsed the US Centers for Disease Control and Prevention’s (CDC) Guidelines for Prescribing Opioids for Chronic Pain as best practices for physicians in Nova Scotia.


Draft Standard of Practice: Physician-Assisted Death  

The College of Physicians and Surgeons of Nova Scotia is seeking input from physicians on a Standard of Practice for Physician-Assisted Death in the province.


College Closes CAPP Program  

The College will not be offering the Clinician Assessment for Practice Program (CAPP) examination going forward and has cancelled the exam scheduled for June, 2015.  


College Launches Prescription Medication Awareness Campaign  

The College of Physicians and Surgeons of Nova Scotia (CPSNS) is launching an awareness campaign aimed at encouraging patients and physicians to explore pain management alternatives.


New Policy Regarding the Authorization of Marijuana for Medical Purposes  

The College of Physicians and Surgeons of Nova Scotia has issued a new policy to help physicians understand their responsibilities pursuant to the new marijuana for medical purposes regulations. 


New Policy Regarding Review of Monitored Drug History Before Prescribing  

Canada is the second largest prescribing nation of opioids in the world.  Nova Scotia is among the provinces with the highest rates of opioid prescribing.